Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
2025 Q2
3 of 19 quarters
Total Value
$20.49M
Total Shares
8.36M
Net Share Change
+3.16M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$20.49M
8.36M
0.3%
ADD
+3.16M
(+60.9%)
Maverick Capital
$20.49M
8.36M shares
ADD
+3.16M
(+60.9%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy